Managing EARLY-STAGE MYELOFIBROSIS via personalised clinical decision making tools and treatment

01 Sep 2021
At the recent Malaysian Myeloproliferative Neoplasms (MPN) Expert Forum, Professor Martin Griesshammer from the Johannes Wesling University Hospital in Germany highlighted the role of personalised clinical decision-making tools and treatment in early-stage myelofibrosis. Chaired by Dr Alan Teh, Consultant Haematologist at Subang Jaya Medical Centre, the virtual forum was organised by Novartis, in collaboration with the Malaysian Society of Haematology (MSH).
Editor's Recommendations